SRT employs small molecules to inhibit the synthesis of substrates that cannot be efficiently degraded due to enzyme deficiencies. By lowering the levels of these substrates, SRT helps to prevent their buildup within lysosomes, thus reducing cellular and tissue damage. This approach is particularly useful in conditions where enzyme replacement therapy (ERT) may not be effective.
